Atara Biotherapeutics (ATRA) Other Non Operating Income (2015 - 2025)
Atara Biotherapeutics (ATRA) posted Other Non Operating Income of -$15000.0 for Q4 2025, down 475.0% on a QoQ basis from $4000.0 in Q3 2025, and up 83.15% year-over-year from -$8190.2 in Q4 2024.
Atara Biotherapeutics (ATRA) Other Non Operating Income (2015 - 2025) Analysis & Trends
Atara Biotherapeutics' Other Non Operating Income history runs 11 years deep, the most recent figure standing at -$15000.0 for Q4 2025.
- Quarterly Other Non Operating Income rose 83.15% year-over-year to -$15000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $11000.0 (down 97.55% YoY) and the FY2024 annual result came in at $528000.0, up 314.63% from the prior year.
- Other Non Operating Income was -$15000.0 for Q4 2025 at Atara Biotherapeutics, down from $4000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $555000.0 in Q3 2024 and bottomed at -$309000.0 in Q3 2022.
- A 5-year average of -$2600.0 and a median of -$11500.0 in 2023 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 2155.56% in 2024, while the deepest fall reached 641.67% in 2024.
- Atara Biotherapeutics' Other Non Operating Income stood at $84000.0 in 2021, then slumped by 182.14% to -$69000.0 in 2022, then soared by 82.61% to -$12000.0 in 2023, then sank by 641.67% to -$89000.0 in 2024, then surged by 83.15% to -$15000.0 in 2025.
- Business Quant data shows ATRA's Other Non Operating Income at -$15000.0 in Q4 2025, $4000.0 in Q3 2025, and $22000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Dec 31, 2024 | -89,000.00 |
| Sep 30, 2024 | 555,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Sep 30, 2023 | -27,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | -197,000.00 |
| Dec 31, 2022 | -69,000.00 |
| Sep 30, 2022 | -309,000.00 |
| Jun 30, 2022 | -214,000.00 |
| Mar 31, 2022 | -109,000.00 |
| Dec 31, 2021 | 84,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Jun 30, 2021 | 225,000.00 |
| Mar 31, 2021 | -90,000.00 |